Abstract
Selective serotonin reuptake inhibitors (SSRIs) have been reported to decrease sexual activity across a broad diagnostic spectrum in men and women. We present a serendipitous finding of fluoxetine-associated suppression of ego-dystonic homosexual activity in a fifty-three year old male for a period of thirteen years thus far. His determination to remain sexually abstinent has been key in his successful treatment.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition. Washington, DC. American Psychiatric Association 522-538, 1994.
Kafka MP. Successful Antidepressant Treatment of Nonparaphilic Sexual Addictions and Paraphilias in Men. J Clin Psychiatry 52(2):60-64, 1991.
Elmore JL. SSRI Reduction of Nonparaphilic Sexual Addiction. CNS Spectrums 5(11):53-56, 2000.
Modell JG, Katholi CR, Modell JD. Comparative Side Effects of Buproprion, Fluoxetine, Paroxetine and Sertraline. Clinical Pharmacology and Therapeutics 61(4):476-87, 1997.
Labbate LA, Grimes JB, Hines A, Pollack MH. Bupropion Treatment of Serotonin Reuptake Antidepressant-Associated Sexual Dysfunction. Annals of Clin Psychiatry 9(4):241-245, 1997.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Elmore, J.L. Fluoxetine-Associated Remission of Ego-Dystonic Male Homosexuality. Sexuality and Disability 20, 149–151 (2002). https://doi.org/10.1023/A:1019834512443
Issue Date:
DOI: https://doi.org/10.1023/A:1019834512443